Free Trial

CochLear (OTCMKTS:CHEOY) Shares Gap Up - Here's What Happened

CochLear logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • CochLear shares gapped up before the open, moving from a close of $33.84 to an open of $35.29 and last trading at $34.1175 on volume of 735 shares.
  • Analysts are mixed: Zacks moved to a "hold," UBS cut from "strong-buy" to "hold," while RBC upgraded to "moderate buy," leaving an average rating of Moderate Buy (1 Strong Buy, 1 Buy, 3 Hold).
  • The stock is trading well below its recent trend levels, with a 50-day moving average of $61.43 and a 200-day moving average of $80.14 versus the current ~$34 price.
  • MarketBeat previews top five stocks to own in May.

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $33.84, but opened at $35.29. CochLear shares last traded at $34.1175, with a volume of 735 shares trading hands.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Zacks Research raised CochLear to a "hold" rating in a research note on Friday, April 17th. UBS Group cut CochLear from a "strong-buy" rating to a "hold" rating in a research note on Thursday. Finally, Royal Bank Of Canada raised CochLear from a "hold" rating to a "moderate buy" rating in a research note on Monday, January 19th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, CochLear presently has an average rating of "Moderate Buy".

Get Our Latest Stock Analysis on CHEOY

CochLear Stock Performance

The stock has a fifty day moving average price of $61.43 and a 200 day moving average price of $80.14.

About CochLear

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CochLear Right Now?

Before you consider CochLear, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.

While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines